We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use feedback from marketplace reviews to evaluate your digital health product.
Being honest and transparent with online reviews and endorsements, including on social media and in other online content.
Evaluations made by the Rapid Review Panel (RRP) on submitted products.
The guide, toolkit and further information for GB authorities with responsibility for consumer product safety.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Guidance on choosing evaluation study types and methods.
How the MHRA makes decisions on whether a borderline product is a medical device and which risk class should apply.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).